Geode Capital Management’s NantHealth, Inc NH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-27,150
| Closed | -$54.4K | – | 4879 |
|
|
2023
Q1 | $54.4K | Hold |
27,150
| – | – | ﹤0.01% | 4497 |
|
|
2022
Q4 | $99K | Sell |
27,150
-69
| -0.3% | -$293 | ﹤0.01% | 4410 |
|
|
2022
Q3 | $100K | Hold |
27,219
| – | – | ﹤0.01% | 4581 |
|
|
2022
Q2 | $170K | Sell |
27,219
-12,939
| -32% | -$121K | ﹤0.01% | 4366 |
|
|
2022
Q1 | $453K | Buy |
40,158
+653
| +2% | +$8.32K | ﹤0.01% | 3981 |
|
|
2021
Q4 | $625K | Sell |
39,505
-1,099
| -3% | -$23.3K | ﹤0.01% | 3932 |
|
|
2021
Q3 | $980K | Sell |
40,604
-1,853
| -4% | -$55.7K | ﹤0.01% | 3686 |
|
|
2021
Q2 | $1.48M | Buy |
42,457
+1,341
| +3% | +$53.3K | ﹤0.01% | 3404 |
|
|
2021
Q1 | $1.98M | Buy |
41,116
+7,212
| +21% | +$418K | ﹤0.01% | 3257 |
|
|
2020
Q4 | $1.64M | Buy |
33,904
+4,939
| +17% | +$186K | ﹤0.01% | 3187 |
|
|
2020
Q3 | $1.02M | Buy |
28,965
+1,490
| +5% | +$84K | ﹤0.01% | 3204 |
|
|
2020
Q2 | $1.89M | Buy |
27,475
+9,066
| +49% | +$361K | ﹤0.01% | 2876 |
|
|
2020
Q1 | $439K | Sell |
18,409
-1,984
| -10% | -$47.5K | ﹤0.01% | 3319 |
|
|
2019
Q4 | $315K | Buy |
20,393
+8
| +0% | +$106 | ﹤0.01% | 3657 |
|
|
2019
Q3 | $223K | Sell |
20,385
-312
| -2% | -$2.77K | ﹤0.01% | 3730 |
|
|
2019
Q2 | $163K | Sell |
20,697
-5,100
| -20% | -$51.9K | ﹤0.01% | 3841 |
|
|
2019
Q1 | $356K | Buy |
25,797
+1,156
| +5% | +$13.4K | ﹤0.01% | 3560 |
|
|
2018
Q4 | $201K | Buy |
24,641
+27
| +0.1% | +$473 | ﹤0.01% | 3680 |
|
|
2018
Q3 | $579K | Buy |
24,614
+734
| +3% | +$27.9K | ﹤0.01% | 3412 |
|
|
2018
Q2 | $1.19M | Buy |
23,880
+2,182
| +10% | +$108K | ﹤0.01% | 3111 |
|
|
2018
Q1 | $992K | Sell |
21,698
-10
| -0% | -$502 | ﹤0.01% | 3131 |
|
|
2017
Q4 | $993K | Buy |
21,708
+1,038
| +5% | +$55K | ﹤0.01% | 3105 |
|
|
2017
Q3 | $1.28M | Buy |
20,670
+14,943
| +261% | +$875K | ﹤0.01% | 3012 |
|
|
2017
Q2 | $363K | Buy |
5,727
+811
| +16% | +$44.9K | ﹤0.01% | 3475 |
|
|
2017
Q1 | $365K | Buy |
4,916
+624
| +15% | +$69.5K | ﹤0.01% | 3434 |
|
|
2016
Q4 | $639K | Buy |
4,292
+530
| +14% | +$93.8K | ﹤0.01% | 3186 |
|
|
2016
Q3 | $742K | Buy |
3,762
+562
| +18% | +$103K | ﹤0.01% | 3090 |
|
|
2016
Q2 | $599K | Buy |
+3,200
| New | +$697K | ﹤0.01% | 3146 |
|
Geode Capital Management's NH Position: Q2 2023 in Review
Geode Capital Management sold out of NantHealth, Inc (NH) in Q2 2023, closing a stake of 27,150 shares — an estimated $54.4K sold.
Geode Capital Management first reported a position in NH in Q2 2016 and held it in 28 quarters. The position peaked at $1.98M in Q1 2021. 0 funds tracked by Wall St. Rank hold NH as of Q2 2023.
- Geode Capital Management reported no remaining NantHealth, Inc position as of Q2 2023 after selling out during the quarter.
- Geode Capital Management sold 27,150 NantHealth, Inc shares in Q2 2023, an estimated $54.4K.
- Geode Capital Management first reported a position in NantHealth, Inc in Q2 2016 and held it in 28 quarters.
- Geode Capital Management's NantHealth, Inc position peaked at $1.98M in Q1 2021.
- 0 funds tracked by Wall St. Rank held NantHealth, Inc as of Q2 2023.
Based on Geode Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.